The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...

head of the HIV Prevention Trials Network says there are four areas of research which are being investigated in HIV; ...

The treatment, which aims to provide immunity against various strains of the virus, produced an anti-HIV immune system response in tests on 393 people, a study in the Lancet found. It also ...

Researchers remain hopeful that they're heading in the right direction to finding a cure for HIV, the virus that causes AIDS. Right now, it’s still out of reach. But the unusual cases of four ...

A small French biotech is trumpeting results from a trial suggesting its developmental drug could be used as part of an HIV cure. The phase 2a trial of AbiVax’s ABX464 pill is small but confirms ...

In an ongoing clinical trial, researchers are testing whether just one dose of a new gene therapy that might effectively cure human immunodeficiency virus (HIV) infections is safe in humans.

Dr Philip Arandjelovic, co-author in the study, said the discovery is an exciting step towards developing treatment options for the tens of millions of people currently living with HIV globally.

The emergence of psychotic symptoms in patients infected with HIV presents a diagnostic challenge. The clinician should consider a primary psychiatric illness (e.g., schizophrenia or bipolar ...

A study of nearly 1,000 gay male couples in The Lancet found no cases of HIV transmission over eight years. This was due to treatment reducing the virus to very low levels in the body.

Gilead (GILD) announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection, ...

After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations. This website will be accessible until September 2025, with all ...